ArrowMark Colorado Holdings’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8M Sell
335,489
-1,239,794
-79% -$67.3M 1.16% 8
2026
Q1
$60.7M Buy
1,575,283
+301,773
+24% +$12.5M 1.61% 9
2025
Q4
$59.2M Buy
1,273,510
+789,364
+163% +$38M 1.3% 13
2025
Q3
$23.8M Sell
484,146
-10,813
-2% -$566K 0.44% 70
2025
Q2
$25.6M Buy
+494,959
New +$20M 0.46% 70

Other funds holding HNGE

ArrowMark Colorado Holdings's HNGE Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Hinge Health (HNGE) stake by 79% in Q2 2026, selling an estimated $67.3M and leaving 335,489 shares worth $27.8M. The position accounts for 1.16% of the portfolio, ranked #8.

ArrowMark Colorado Holdings first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $60.7M in Q1 2026. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • ArrowMark Colorado Holdings held 335,489 shares of Hinge Health worth $27.8M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 1,239,794 Hinge Health shares in Q2 2026, an estimated $67.3M.
  • Hinge Health made up 1.16% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #8 holding.
  • ArrowMark Colorado Holdings first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • ArrowMark Colorado Holdings's Hinge Health position peaked at $60.7M in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.